Treatment of First Recurrences of Clostridium difficile-Associated Disease: Waiting for New Treatment Options

A major question arising in the infectious diseases community is whether and when to abandon the use of metronidazole as first-line therapy for C. difficile diarrhea, both for initial and recurrent episodes in the face of the changing epidemiology of this reemerging infectious disease [2, 3]. In the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2006-03, Vol.42 (6), p.765-767
1. Verfasser:	Louie, Thomas J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Bacteria Clinical trials Clostridium difficile - pathogenicity Disease Outbreaks Drug therapy Enterocolitis, Pseudomembranous - drug therapy Enterocolitis, Pseudomembranous - epidemiology Humans Mortality Quebec - epidemiology Recurrence Risk Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!